M. van Vliet
- Co-authors
- Arnold G. VultoPeter DevileeAlbert HofmanLoes E. VisserRon H. N. van SchaikCornelia M. van DuijnR.S. CornelisMarc J. van de Vijver
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Cancer-related Molecular Pathways (5 papers)Multiple Myeloma Research and Treatments (4 papers)
- Cited by
- PharmacologyPhysiologyOncology
- Journals
- Proceedings of the National Academy of SciencesNucleic Acids ResearchJournal of Clinical Oncology
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
M. van Vliet
33 papers receiving 757 citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 285
- Pharmacology 245
- Oncology 204
- Genetics 159
- Cancer Research 93
Countries citing papers authored by M. van Vliet
This map shows the geographic impact of M. van Vliet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. van Vliet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. van Vliet more than expected).
Fields of papers citing papers by M. van Vliet
This network shows the impact of papers produced by M. van Vliet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. van Vliet. The network helps show where M. van Vliet may publish in the future.
Co-authorship network of co-authors of M. van Vliet
This figure shows the co-authorship network connecting the top 25 collaborators of M. van Vliet. A scholar is included among the top collaborators of M. van Vliet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. van Vliet. M. van Vliet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | Mali (Vol 9, 2012) | 1 |
| 8 | 38 | |
| 9 | 37 | |
| 10 | 67 | |
| 11 | 7 | |
| 12 | 72 | |
| 13 | 79 | |
| 14 | 15 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 40 | |
| 18 | 18 | |
| 19 | 2 | |
| 20 | 29 |
About M. van Vliet
M. van Vliet is a scholar working on Pharmacology, Hematology and Oncology, having authored 35 papers that have together received 785 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Cancer-related Molecular Pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Pharmacology (245 citations), Physiology (59 citations) and Oncology (204 citations). M. van Vliet has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Arnold G. Vulto, Peter Devilee, Albert Hofman, Loes E. Visser, Ron H. N. van Schaik, Cornelia M. van Duijn, R.S. Cornelis, Marc J. van de Vijver, P. Meera Khan and Ron HN van Schaik. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.